The news arrived Monday that the world has been awaiting since spring: a vaccine has been developed that shows a high degree of efficacy in late-stage trials: 90%. That puts it in the company of effective vaccines such as for measles, and well beyond what the medical community hoped for...

Policy has limited impact on vaccine uptake because of individual decision making, study finds

Brandon Brown is an associate professor in the School of Medicine at UC Riverside